# A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

> **NCT07225569** · PHASE2 · RECRUITING · sponsor: **Sanofi** · enrollment: 144 (estimated)

## Conditions studied

- Hidradenitis Suppurativa

## Interventions

- **DRUG:** SAR445399
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07225569
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-29
- **Primary completion:** 2027-09-22
- **Final completion:** 2027-12-01
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07225569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07225569, "A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07225569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*